# Shin Nippon Biomedical Laboratories, Ltd. (2395.T): MoatMap facts

As of 13 Nov 2026. Research data, not investment advice.

As of 13 Nov 2026, the MoatMap Score for Shin Nippon Biomedical Laboratories, Ltd. (2395.T) is 77/100, ranked against 25,000+ stocks in 38 markets (Quality 51, Value 70, Momentum 54, each scored against its sector).

- MoatMap Score: 77/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 51, Value 70, Momentum 54: each a 0-100 percentile within Healthcare.
- Position: #6,004 overall, #640 in Healthcare.
- Listing: Japan, JPX; Healthcare / Diagnostics & Research.
- Last close: 1,229 JPY on 12 Nov 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/2395.T
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker